- $745.91m
- $756.30m
- $763.86m
- 68
- 56
- 73
- 71
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 374.12 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.77 | ||
Price to Tang. Book | 5.98 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.98 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -5.67% | ||
Return on Equity | -7.55% | ||
Operating Margin | -3.03% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 567.19 | 637.8 | 698.64 | 688.09 | 763.86 | 841.76 | 928.01 | 10.41% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +27.14 | -67.87 | -29.34 | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE) program, it fulfills a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.
Directors
- Patrick Blair PRE (50)
- Barbara Gutierrez CFO (58)
- Maria Lozzano COO (41)
- Robin Doerr CMO (57)
- Gina Deblassie OTH
- Melissa Welch OTH (60)
- Last Annual
- June 30th, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- October 28th, 2015
- Public Since
- March 4th, 2021
- No. of Shareholders
- 10
- No. of Employees
- 2,350
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 135,620,541
- Address
- 8950 E. Lowry Boulevard, DENVER, 80230
- Web
- https://www.innovage.com/
- Phone
- +1 3038694664
- Auditors
- Deloitte & Touche LLP
Upcoming Events for INNV
InnovAge Holding Corp Annual Shareholders Meeting
Q2 2025 InnovAge Holding Corp Earnings Release
Similar to INNV
Acadia Healthcare
NASDAQ Global Select Market
Accolade
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
Amedisys
NASDAQ Global Select Market
FAQ
As of Today at 15:21 UTC, shares in InnovAge Holding are trading at $5.50. This share price information is delayed by 15 minutes.
Shares in InnovAge Holding last closed at $5.50 and the price had moved by -1.79% over the past 365 days. In terms of relative price strength the InnovAge Holding share price has underperformed the S&P500 Index by -26.42% over the past year.
The overall consensus recommendation for InnovAge Holding is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreInnovAge Holding does not currently pay a dividend.
InnovAge Holding does not currently pay a dividend.
InnovAge Holding does not currently pay a dividend.
To buy shares in InnovAge Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.50, shares in InnovAge Holding had a market capitalisation of $745.91m.
Here are the trading details for InnovAge Holding:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: INNV
Based on an overall assessment of its quality, value and momentum InnovAge Holding is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in InnovAge Holding is $6.50. That is 18.18% above the last closing price of $5.50.
Analysts covering InnovAge Holding currently have a consensus Earnings Per Share (EPS) forecast of -$0.01 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like InnovAge Holding. Over the past six months, its share price has outperformed the S&P500 Index by +10.32%.
As of the last closing price of $5.50, shares in InnovAge Holding were trading +5.57% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The InnovAge Holding PE ratio based on its reported earnings over the past 12 months is 374.12. The shares last closed at $5.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
InnovAge Holding's management team is headed by:
- Patrick Blair - PRE
- Barbara Gutierrez - CFO
- Maria Lozzano - COO
- Robin Doerr - CMO
- Gina Deblassie - OTH
- Melissa Welch - OTH